Armstrong AJ, et al. Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial. ASCO-GU 2019, abstract 29.
Bevolkingsonderzoek darmkanker leidt bij 3,6 procent tot diagnose
okt 2014